Exact Sciences (EXAS) Gains from Sales and Divestitures (2010 - 2019)

Exact Sciences (EXAS) has 10 years of Gains from Sales and Divestitures data on file, last reported at $3.5 million in Q2 2019.

• Gains from Sales and Divestitures for Q2 2019 came in at $3.5 million, up 271.43% year-over-year; the trailing twelve-month figure through Jun 2019 was $3.5 million (up 271.43% YoY), and the FY2018 annual result was $1.3 million, up 12.85% from the prior year.
• Gains from Sales and Divestitures climbed to $3.5 million in Q2 2019 per EXAS's latest filing, from $3.4 million in the prior quarter.
• Over five years, Gains from Sales and Divestitures peaked at $3.5 million in Q2 2019 and troughed at $237061.0 in Q1 2015.
• A 5-year average of $1.1 million and a median of $817710.0 in 2016 frame the typical range for Gains from Sales and Divestitures.
• The sharpest annual moves came in 2018 and 2019: Gains from Sales and Divestitures increased 11.84% in 2018, then surged 286.5% in 2019.
• A 5-year view of Gains from Sales and Divestitures shows it stood at $578033.0 in 2015, then soared by 37.74% to $796168.0 in 2016, then surged by 42.21% to $1.1 million in 2017, then climbed by 12.85% to $1.3 million in 2018, then surged by 174.4% to $3.5 million in 2019.
• Business Quant data shows EXAS's Gains from Sales and Divestitures at $3.5 million in Q2 2019, $3.4 million in Q1 2019, and $1.3 million in Q4 2018.